Elevar Therapeutics Announces Publication of Phase 3 CARES 310 Study Results in The Lancet
July 24, 2023 21:39 ET
|
Elevar Therapeutics
FORT LEE, N.J., July 24, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
July 21, 2023 02:15 ET
|
Turnstone Biologics Corp.
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure...
Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in Combination with Camrelizumab as a First-line Treatment for Unresectable Hepatocellular Carcinoma
July 17, 2023 09:00 ET
|
Elevar Therapeutics
FORT LEE, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd., and a fully integrated biopharmaceutical company dedicated to elevating...
"The Future of Medical Procedures: Understanding the Radiofrequency Ablation Devices Market (+CAGR of 11.6%) ", Says Market.us
July 05, 2023 08:59 ET
|
Market.Us
New York, July 05, 2023 (GLOBE NEWSWIRE) -- The Radiofrequency Ablation Devices Market in terms of revenue was estimated to be worth USD 4.3 Bn in 2022 and is poised to reach USD 12.5 Bn by 2032,...
Antibody Drug Conjugates Market to surpass USD 26.5 billion by 2032, says Global Market Insights Inc.
June 20, 2023 20:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, June 20, 2023 (GLOBE NEWSWIRE) -- Antibody Drug Conjugates Market size will cross USD 26.5 billion by 2032. Growing advancements in antibody engineering and conjugation...
Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment
June 20, 2023 04:00 ET
|
AKAMPION
IMAGIO consortium of clinical partners coordinated by Philips receives EUR 24 million grant from the Innovative Health Initiative (IHI) and additional funding from industry partners to support the...
Hyperthermia Cancer Treatment Market to Grow 5.9% CAGR, Worth US$ 266 Million by 2030 | TMR Study
June 02, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 02, 2023 (GLOBE NEWSWIRE) -- The global hyperthermia cancer treatment market stood at US$ 147.6 million in 2019 and the global market is projected to reach...
Radiation Oncology Market to hit US$ 19.2 Billion by 2032, Expanding Rapidly at a CAGR of 9.1%: Market.us Report
May 24, 2023 09:44 ET
|
Market.Us
New York, May 24, 2023 (GLOBE NEWSWIRE) -- It is anticipated that the Radiation oncology industry may increase from US$ 8.2 billion in 2023 to US$ 19.2 billion by 2032. Between 2022 and 2032, the...
Tumor Ablation Market size to grow by US$ 4,389 Million by 2032, North America to account for 37% of the market growth - Market.us
May 24, 2023 05:28 ET
|
Market.Us
New York, May 24, 2023 (GLOBE NEWSWIRE) -- The tumor ablation market size reached US$ 1,333 Million in 2022. Looking forward, Market.us expects the market to reach US$ 4,389 Million by 2032,...
Cancer Treatment Market to Grasp Outstanding Growth of USD 524,921.84 Million by 2029, Size, Share, Trends, Key Drivers, Growth Opportunities and Competitive Outlook
May 23, 2023 07:30 ET
|
Data Bridge Market Research
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research has released a new report titled "Cancer Treatment Market" which delves deep into growth strategies, drivers, opportunities,...